Atlas Trials

Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

Clinical trial NCT05667714 · UNKNOWN

Trial details

NCT number
NCT05667714
Sponsor
Sinovac Life Sciences Co., Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19
Start date
2022-11-26
Primary completion
2022-12-30
Enrollment
2900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.